, /PRNewswire/ -- (Alveo), a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced that rigorous development and testing has demonstrated that the Flockscreen LAMP Avian Influenza Molecular Test can accurately detect the presence of virus in both cloacal and oropharyngeal samples from poultry with comparable limit of detection, sensitivity and specificity. Alveo and their development partners performed more than 20,000 reactions on over 4000 assay cartridges during their evaluation of over 100 candidate primer sets and assay conditions, using both contrived and clinical samples. Relevant regulatory bodies have been engaged and appropriate validation and verification activities will be completed prior to shipment.
The product is available today for pre-sale in and the . The company expects to begin shipping in volume in the third quarter of 2024. The current HPAI panzootic has recently spread to cattle and at least species.
Due to current disease control legislation, this has led to the destruction of more than worldwide. Rapid, accurate tests are vital for early detection and containment, protection of the poultry industry, the prevention of zoonotic transmission and spillover events from one species to another, food security, the maintenance of agricultural trade, and ongoing monitoring and surveillance. Current agricultural tests for highly pathogenic avian influenza (HPAI) all suffer from one of several significant drawbacks .
